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Abstract
Infectious endocytosis of incoming human papillomavirus type 16 (HPV-16), the main etiological agent of cervical cancer, is
poorly characterized in terms of cellular requirements and pathways. Conflicting reports attribute HPV-16 entry to clathrin-
dependent and -independent mechanisms. To comprehensively describe the cell biological features of HPV-16 entry into
human epithelial cells, we compared HPV-16 pseudovirion (PsV) infection in the context of cell perturbations (drug
inhibition, siRNA silencing, overexpression of dominant mutants) to five other viruses (influenza A virus, Semliki Forest virus,
simian virus 40, vesicular stomatitis virus, and vaccinia virus) with defined endocytic requirements. Our analysis included
infection data, i.e. GFP expression after plasmid delivery by HPV-16 PsV, and endocytosis assays in combination with
electron, immunofluorescence, and video microscopy. The results indicated that HPV-16 entry into HeLa and HaCaT cells
was clathrin-, caveolin-, cholesterol- and dynamin-independent. The virus made use of a potentially novel ligand-induced
endocytic pathway related to macropinocytosis. This pathway was distinct from classical macropinocytosis in regards to
vesicle size, cholesterol-sensitivity, and GTPase requirements, but similar in respect to the need for tyrosine kinase signaling,
actin dynamics, Na
+/H
+ exchangers, PAK-1 and PKC. After internalization the virus was transported to late endosomes and/
or endolysosomes, and activated through exposure to low pH.
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Introduction
Human Papillomaviruses (HPVs) are a family of small non-
enveloped viruses that induce mostly benign papillomas. However,
several high risk HPV types, most prominently HPV-16, cause
cervical cancer and other epithelial tumors. While the molecular
biology of transformation has been studied in some detail [1], the
cell biology of HPV-16 entry is still a subject of scientific debate
[2]. Transmission is conferred by virions that contain two
structural proteins, L1 and L2. These provide an icosahedral
(T=7) capsid of 52–55 nm that protects the closed, circular,
double-stranded DNA genome. HPVs initially enter basal cells of
stratified epithelia [3]. The productive life cycle of HPVs requires
differentiating human epidermal tissue allowing only limited
infectious virus production in vitro. As a surrogate model, entry
into a variety of cell lines has been studied using HPV virus-like
particles (VLP) or pseudovirions (PsV) [4–9], i.e. viral capsids
harbouring a reporter plasmid [10].
HPV-16canbindto cellsurface receptors and to the extracellular
matrix (ECM). Binding to cells occurs through interaction with
glycosaminoglycans (GAGs), mostly heparan sulfate proteoglycans
(HSPGs, [11–14]). Binding to the ECM may additionally involve
laminin-332 [15]. Binding results in conformational changes in the
capsid that allow partial externalization of the inner virion protein
L2 by cyclophilin B. This, in turn, leads to cleavage of the N-
terminus proximal sequence of L2 by furin [16–20]. Transfer from
HSPGs to a putative secondary receptor has been proposed to
precede infectious internalization [21].
The literature on papillomavirus entry does not allow a
generalized view regarding the mode of endocytosis. Several studies
with HPV-16, HPV-31, and BPV-1 have relied on the small
compound inhibitor chlorpromazine to suggest entry by clathrin-
mediated endocytosis (CME) [5,6,22]. In addition, dynamin-2 has
been suggested as a mediator in primary endocytic vesicle (PEV)
formation for HPV-16 [4]. However, recent studies challenge an
unambiguous role of CME in entry of papillomaviruses: HPV-31
entry into keratinocytes has been attributed to caveolar/lipid-raft
mediated endocytosis [5,8], and Spoden and colleagues [9]
suggested that HPV-16 entry into 293TT and HeLa cells occurs
through tetraspanin-enriched microdomains, and is clathrin-, lipid
raft- and dynamin-independent. As a minimal consensus, all studies
agree that HPV-16 entry is insensitive to cholesterol depletion, but
sensitive to lysosomotropic agents. Some of the confusion may be
explained by the use different VLP/PsV preparations and cell lines.
PLoS Pathogens | www.plospathogens.org 1 April 2012 | Volume 8 | Issue 4 | e1002657In this study, we addressed HPV-16 entry by systematically
perturbing the function of numerous cellular key factors implicated
in the various endocytic mechanisms known to date using
chemical inhibitors, siRNA silencing, and overexpression of
dominant negative (DN) proteins. Immunofluorescence analysis,
live cell imaging, and thin section electron microscopy were used
to analyze viral colocalization or cotrafficking with cellular factors,
and to visualize the morphology of virus-containing vesicles. To
circumvent some limitations that cellular endocytic ligands may
pose for a comparative analysis such as monovalency, lesser or
higher sensitivity to pertubations, different time courses, etc., we
used viruses with known endocytic requirements as controls, i.e.
simian virus 40 (SV40), Semliki Forest virus (SFV), influenza A
virus (IAV), vesicular stomatitis virus (VSV), and vaccinia virus
(VV). The results indicated that HPV-16 entry was clathrin-,
caveolin-, flotillin-, cholesterol-, and dynamin-independent and
did not involve the glycosphingolipid enriched endocytic carrier
(GEEC) pathway, the Arf6 pathway, and the IL-2 pathway. In
contrast, HPV-16 made use of a potentially novel endocytic
pathway possibly related to macropinocytosis, which was depen-
dent on actin dynamics and tyrosine kinase signaling. The viruses
were carried to late endosomes/lysosomes and underwent slow
acid-dependent penetration.
Results
Kinetics of HPV-16 endocytosis
First, we analyzed how rapidly infectious cell-bound HPV-16
particles were internalized by endocytosis in HeLa and HaCaT
cells. To distinguish between external and internalized viruses, we
used a high pH wash to inactivate the PsV located on the cell
surface (see Figure S1 A, B, and material and methods for details).
HPV-16 PsV were bound to cells in the cold, unbound virus was
washed away, and the cells were warmed to 37uC. At different
times post warming, cells were subjected briefly to a high pH wash
and infection was scored after 48 h by the detection of GFP
expression from the PsV reporter plasmid using flow cytometry.
This way the internalization exclusively of infectious particles
was probed.
When using a low multiplicity of infection (MOI, 0.1 tdu/cell),
so that a single infectious particle per cell caused infection, we
found that about 2 h at 37uC were needed for the first viruses to be
internalized. The half-time for the entire population was 11 h
(Figure 1A, black). When a higher MOI (10 tdu/cell) was used,
infectious internalization by the first (fastest) of several infectious
particles caused infection providing information regarding the
fastest possible internalization kinetics. The fastest particles
provided a half time of internalization of 4 h post warming with
no apparent lag time (Figure 1A, white). Similar internalization
kinetics were observed in HaCaT cells (Figure 1B).
When internalization of fluorescently labeled HPV-16 particles
was analyzed by scoring cell-associated fluorescence after remov-
ing cell surface-bound viruses by protease digestion at different
times post warming, similar kinetics as compared to the high MOI
infectious internalization were observed (data not shown). This
suggested that all particles, infectious and non-infectious, followed
a similar itinerary.
With half times of internalization ranging from 4–12 h p.i. for
the fastest and average particles, our data was consistent with
previous observations, where bulk internalization of papillomavi-
ruses and PsV was shown to be extremely slow [6,23,24]. To our
knowledge, this describes the slowest internalization kinetics
observed for a virus.
Endocytic internalization of individual viruses in live cells can
be visualized using total internal reflection microscopy (TIRFM)
by the loss of fluorescence as vesicles leave the evanescent field
[25]. We used fluorophore labeled PsV that can be easily followed
by microscopy and retain their infectivity after labelling [7]. As
papillomavirus entry has been mostly attributed to CME, we
analyzed internalization of AF488-labeled virions in cells express-
ing clathrin light chain tagged with mRFP (CLC-RFP) to follow
any potential cointernalization.
After binding to cells, HPV-16 particles exhibit periods of lateral
diffusion and directed transport, after which movement stops [7].
Such confinement is often associated with the interaction of
plasma membrane receptors with the actin cytoskeleton or
endocytic coat elements [26]. We analyzed how quickly the
fluorescence of HPV-16 PsV particles was lost after confinement,
an event consistent with internalization. The majority of particles
stayed confined and were not internalized during data acquisition
possibly due to HPV-16 anchoring to ECM factors and plasma
membrane receptors [15,27]. However, internalization of several
particles (30 min p.i., n=17; 2 h p.i., n=31) could be observed,
and when that happened it occurred on average within 120 s post
confinement (Figure 1C, Video S1). The fastest event occurred
93 s after confinement. The formation and endocytosis of clathrin
coated pits was readily observed by TIRFM in HeLa cells.
Consistent with previous reports, the full cycle lasted about 60 s
(Figure 1C) [28,29]. Cointernalization of HPV-16 and clathrin
was not observed. Thus we found that single virus internalization
events were fast, but occurred only sporadically over a period of
many hours. The absence of any clathrin signal during inter-
nalization suggested a clathrin-independent endocytosis event.
Analyzing HPV-16 entry by perturbations
This prompted us to reinvestigate the endocytic requirements of
HPV-16 entry. We used small compound inhibitors, siRNA-
mediated depletion, and overexpression of DN proteins to identify
the cellular factors required or dispensable for infectious
endocytosis.
To reduce potential cytotoxic effects of cellular inhibitors, the
inhibitors were replaced after the entry phase was over by a less
toxic inhibitor such as NH4Cl that blocked acid-activation of viruses
inendosomes(Figure S2A).Swappingfora second inhibitorallowed
us to assess the effect of an inhibitor of interest on pre-acidification
in the entry process such as binding, endocytosis and perhaps
intracellular routing (compare Figure S2A, Table S1, and material
and methods). The infection data was normalized to cells in which
Author Summary
Human papillomavirus type 16 is the main etiological agent
of cervical cancer. Despite advances inourunderstanding of
transformation and cancer progression, as well as preven-
tative vaccination strategies, the early events in papilloma-
virus infections are incompletely understood. Here, we
investigated which strategies and cellular mechanisms the
virus uses to enter epithelial cells. Entry was slow and
asynchronous likely due to several structural alterations,
which neededto occuron the cell exterior. Interestingly, the
virus hijacked a potentially novel pathway of endocytosis
for entry,which wasdistinct from classicalmacropinocytosis
in regards to vesicle size, cholesterol-sensitivity, and GTPase
requirements, but similar in respect to tyrosine kinase
signaling, actin dynamics, Na
+/H
+ exchangers, PAK-1 and
PKC requirements. This cellular mechanism may also be
used by other viruses such as influenza A virus, echo virus 1,
and choriomeningitis virus.
Clathrin- and Lipid Raft-Independent HPV-16 Entry
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data that exhibited significant cytotoxic effects, i.e. a reduction of
cell number by more than 50% for a given pertubation. Infection
and cytotoxicity was analyzed by automated microscopy and
computational analysis of cell number and infection (see Figure S2B
and material and methods for details).
To minimize erroneous interpretation of data, and to exclude
pleiotrophic effects beyond cell toxicity, we controlled for the
specificity and efficiency of inhibition using prototype virus
infection experiments using the same inhibitor. In addition, cell
biological controls such as transferrin uptake for CME were more
sensitive to pertubation than virus infection (data not shown).
Here, we used SFV and VSV as controls entering by CME, and
SV40 using caveolar/lipid-raft dependent endocytosis. Further
controls included infection by VV for macropinocytosis, and IAV
for penetration of late endosomal compartments. To stay within
one experimental system for comparison of the different viruses,
we used HeLa cells but verified key findings for HPV-16 in
HaCaT cells. Since the dominant effect of mutant proteins often
depends on the level of overexpression, we analyzed infection of
transfected cells by flow cytometry and grouped the data into low,
medium, and high mutant protein expressing cells (Figure S2C).
HPV-16 entry is clathrin-, caveolin-, and flotillin-
independent
First,weanalyzedwhetherinfectionofHPV-16 inHeLa cellswas
clathrin-dependent. To inhibit CME, we used siRNA to deplete the
clathrin heavy chain or the m subunit of the clathrin adaptor AP2. A
depletion to 20% or less of the protein levels in control cells resulted
in efficient decrease in SFV infection (Figure 2A, Figure S3A), a
virus that enters exclusively by CME [30–32]. HPV-16 infection
was not significantly affected (Figure 2A), indicating that HPV-16
entry was clathrin- and AP2-independent. This was consistent with
the TIRFM results described above.
Chlorpromazine, generally considered an inhibitor of CME,
abolished HPV-16 infection at 10 mg/ml in line with earlier
studies [5,8,22]. At this concentration, chlorpromazine also
partially affected infection of SV40, a virus that makes use of
CME-independent endocytosis (Figure 2B). Since efficient clathrin
and AP2 depletion did not affect HPV-16 infection, we suspected
chlorpromazine to cause CME-independent inhibition of entry.
TotestwhetherHPV-16wasusingacaveolin/lipidraft-mediated
pathway, we depleted cells of cholesterol with nystatin/progester-
one, a combination of drugs often used to inhibit fomation of lipid
rafts in the plasma membrane [33]. SV40 infection, which uses a
combination of a caveolar and a caveolin-independent lipid raft-
mediated mechanism [34–36], was efficiently inhibited (Figure 2C).
SFV infection was also affected most likely due to its cholesterol-
dependent membrane fusion activity [37]. However, HPV-16 entry
was, if anything, increased (Figure 2D). Similarly, cholesterol
extraction by methyl-ß-cyclodextrin had only little effect (Table S1).
We found, moreover, that HPV-16 infected HeLa cells depleted of
caveolin-1 and caveolin-1 knockout cells with the same efficiency as
wild-type cells(Figure2D, E,FigureS3B). SinceSV40canmake use
of a caveolin-independent lipid-raft dependent pathway [34], and
since cholera toxin B, that can enter cells by caveolar endocytosis,
can make use of multiple pathways [38], meaningful positive
controls could unfortunately not be employed.
To test whether endocytosis of HPV-16 would involve flotillins,
proposed to define a distinct endocytic mechanisms[39], we depleted
cellsofflotillin-1 or-2,orboth bysiRNAmediated knockdown.Since
no viral cargo exists for flotillin endocytosis, and since cholera toxin B
can use multiple pathways, again, no direct positive controls could be
used. Independent or combined depletion of flotillin-1 and -2 to 20%
protein levels or less of control cells had no effect on HPV-16
infection, whereas SV40 infection was enhanced after flotillin-2 but
not -1 knockdown (Figure 2F, Figure S3C).
We observed no significant colocalization of HPV-16 with
caveolin-1 or flotillin-1 at 2 h post warming by confocal microscopy
(Figure 2G–J). At 8 h, the degree of colocalization between HPV-16
and caveolin or flotillin increased slightly (Figure 2H–J). The
colocalizing objects were mostly located intracellularly and
perinuclearly, which suggested that they belonged to a population
of endosomal vacuoles (Fig. 2G, H; [35,40]).
In summary, infectious HPV-16 entry was independent of
clathrin, AP2, caveolin, lipid rafts and flotillin, and HPV-16 did
not associate with caveolin or flotillin at the cell surface. This
indicated that HPV-16 entry occurred by a distinct endocytic
mechanism.
HPV-16 entry is dynamin-2 independent
Dynamin-2 facilitates membrane fission to generate endocytic
vesicles in several endocytic pathways [41,42]. To test its
involvement in HPV-16 entry, we used overexpression of the
DN K44A mutant, the inhibitor dynasore, and siRNA depletion of
dynamin-2 as methods of pertubation. Overexpression of K44A
dynamin-2 deficient in GTP hydrolysis reduced infection of SFV
or SV40 (Figure 3B, C) in a dose dependent manner to 40% or
50% of control, respectively,whereas HPV-16 entry was only
slightly perturbed (Figure 3A). Dynamin-2 depletion had no
significant effect on HPV-16 infection (Table S1). Dynasore, a
noncompetitive inhibitor of dynamin-2, reduced infection of SFV
and SV40 to 30% and 40%, respectively (Figure 3D). In contrast,
HPV-16 entry was enhanced by up to 50% relative to control
(Figure 3D). Our data suggested that dynamin-2 was not required
for HPV-16 endocytosis.
HPV-16 entry is facilitated by actin polymerization
dynamics independently of Rho GTPase signaling and
actomyosin contractility
Actin polymerization plays a role in several endocytic pathways.
During phagocytosis and macropinocytosis it causes outward
Figure 1. HPV-16 internalization events are fast and occur asynchronously over several hours. To test the average internalization kinetics
of infectious HPV-16 PsV, HeLa (A) or HaCaT (B) cells were infected with HPV-16 PsV at MOIs of 0.1 vs. 10 transducing units/cell, i.e. about 10 vs. 1,000
particles/cell (black vs. white circles, respectively). Virus was bound to cells at 4uC, warmed to 37uC and at indicated times post warming, i.e. post
infection (p.i.), cells were treated with pH 10.5 for 1 min. to inactivate extracellular virus. 48 h p.i. cells were analyzed for GFP expression from the PsV
reporter plasmid by flow cytometry. The amount of GFP expressing cells relative to untreated control is given as relative internalization in %. (C) To
test the internalization kinetics of single particles, we infected HeLa cells with HPV-16 PsV labeled with AF488 (5,000 particles/cell, HPV-16 AF488,
green). Cells were transfected 16 h prior to infection with a construct expressing clathrin light chain-mRFP (red) to investigate any potential
cointernalization. Depicted are TIRFM images of an uninfected (C, above) and infected (C, below) cell. Kymographs to the right of the images depict
the formation and internalization of a CCP or virus (encircled in the images, also shown in Video S1), respectively. Internalization was defined as the
loss of fluorescent signal. The time span required for CCP formation or virus internalization was determined from the initial detection of fluorescence
to complete loss of fluorescence for CCPs, or from the moment of confinement to loss of fluorescence for HPV-16, respectively. The results were
quantified manually and plotted (C, far below).
doi:10.1371/journal.ppat.1002657.g001
Clathrin- and Lipid Raft-Independent HPV-16 Entry
PLoS Pathogens | www.plospathogens.org 4 April 2012 | Volume 8 | Issue 4 | e1002657Figure 2. HPV-16 entry is clathrin-, caveolin-, cholesterol- and flotillin-independent. (A) HeLa cells were transfected with siRNA oligos
directed against the AP2m-subunit (AP2), clathrin heavy chain (CHC), or as control against luciferase. Cells were infected with HPV-16 PsV or SFV and
infection was scored 24 or 6 h p.i. by flow cytometry, respectively. Depicted are the mean infection percentages relative to the luciferase control. (B)
HeLa cells were pretreated for 30 min with chlorpromazine in the indicated concentrations. Cells were infected with HPV-16 PsV (black), SFV (grey), or
SV40 (white) in the presence of inhibitor. Inhibitors were exchanged for HPV-16 and SV40 with NH4Cl or DTT, respectively. Infection was scored by
automated microscopy and image analysis. Depicted are results normalized to solvent treated control cells. See also Figure S2, and material and
methods. (C) HeLa cells were pretreated overnight with nystatin/progesterone in the indicated concentrations. Cells were infected with HPV-16 PsV
(black), SFV (grey), or SV40 (white) and analyzed as in (B). (D) HeLa cells were transfected with siRNA oligos directed against caveolin-1 or with the
AllStar negative control (Qiagen). 48 h after siRNA transfection cells were infected with HPV-16 PsV (black) or VSV (grey). Infection was scored as in (B)
and depicted relative to cells transfected with the AllStar negative control. (E) Mouse embryonic fibroblasts from caveolin-1 knockout mice or
parental mice were infected with HPV-16 PsV at different MOI. Infection was scored by flow cytometry as described in material and methods.
Depicted are infection percentages. (F) HeLa cells were transfected with siRNA oligos directed against flotillin-1 or 22 or with the AllStar negative
control (Qiagen). 48 h after siRNA transfection cells were infected with HPV-16 PsV (black) or SV40 (white). Infection was scored as in (C) and depicted
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ization but not outward protrusion of the plasma membrane is
required in caveolar/lipid raft endocytosis, the IL-2, the glyco-
sphingolypid enriched endocytic compartment (GEEC), and the
Arf6 pathways [41,42].
To test the involvement of actin, we used the actin
depolymerizing agent cytochalasin D and the stabilizing agent
jasplakinolide. As expected, the drugs strongly inhibited SV40
infection, whereas SFV infection was unperturbed by jasplakino-
lide but strongly enhanced by cytochalasin D (Figure 4A, B). Since
HPV-16 infection was efficiently inhibited by both drugs
(Figure 4A, B, Table S1), we concluded that actin dynamics
facilitated infection, in line with previous studies on HPV-16
uptake in BHPE cells or HPV-33 entry into COS-7 cells [23,43].
Since actin polymerization is most critical during macropino-
cytic/phagocytic protrusion of the plasma membrane, we checked
if HPV-16 infection would be affected by inhibition of the Na
+/H
+
exchanger, considered to be a hallmark of macropinocytosis [44].
SFV and SV40 infection were only mildly affected upon EIPA
treatment, whereas HPV-16 infection was effectively reduced
(Figure 4G), so that we concluded that the Na
+/H
+ exchanger is
involved.
During macropinocytosis, actin polymerization events are
regulated by the Rho-like GTPases Cdc42 and Rac1, whereas
phagocytosis and caveolar/lipid-raft endocytosis depend on RhoA
[42,44,45]. We first inhibited RhoA by C3 toxin, and all Rho-like
GTPases by toxin B. C3 toxin, as expected, partially inhibited
SV40 infection, but did not affect HPV-16 entry (Figure 4C).
Toxin B inhibited SFV infection and SV40 infection, but HPV-16
infection was unperturbed (Figure 4C).
Since Rho-like GTPases are key regulators of actin polymeriza-
tion, we wanted to verify these results. We overexpressed Cdc42,
Rac1, and RhoA, and their DN (T17/19N) or constitutively active
(CA, Q61L, G14V) mutants. None of the mutants affected HPV-16
entry (Figure 4D). However, when we infected Cdc42 expressing
cells with vaccinia virus (IHD-J/GFP), which enters cells by
macropinocytosis [46,47], the DN mutant blocked infection by
about 50% (Figure 4E). Hence, we concluded that HPV-16
infection occurred by an endocytic mechanism dependent on actin
polymerization but independent of signaling via the classical Rho-
like GTPases.
Arf6, another small GTPase, has been implicated in macro-
pinocytosis and in an elusive endocytic pathway that occurs in
HeLa cells [48,49]. Arf6 also has the potential to stimulate actin
polymerization [50]. Hence, we tested whether Arf6 might be
regulating actin dynamics during HPV-16 endocytosis. HPV-16
entry was unaffected by overexpression of the CA (Q67L) or DN
(T27N) mutant (Figure 4F). In addition, siRNA mediated silencing
of Arf6 did not affect HPV-16 entry (Table S1). We concluded that
HPV-16 endocytosis did not involve an Arf6 mediated pathway,
and that actin dynamics during HPV-16 entry were not regulated
by Arf6.
Also, actomyosin contractility was not required for entry, as
inhibitors of myosin II and myosin light chain kinase only mildly
reduced infection consistent with their role in transport of HPV-16
along filopodia by actin retrograde flow (Table S1, [7]).
Signaling involved in HPV-16 infection
Specific cellular signals are required for activating different
endocytic pathways [41,42,51]. Hence, we analyzed the role of
major kinases and phosphatases involved in endocytic uptake and
their effect on HPV-16 entry. Genistein-mediated inhibition of
tyrosine kinases blocked HPV-16 entry (Figure 5A). As expected,
SV40 infection was likewise affected (Figure 5A, [34,36]), while
SFV infection was unaffected (Fig. 5A). Similarly, inhibition of
serine/threonine kinases with H-7 blocked HPV-16 and SV40
infection but not SFV infection (Figure 5B). When we inhibited
phosphatases by the broad inhibitor orthovanadate, entry of
relative to cells transfected with the AllStar negative control. (G, H) Merge images of a single cLSM slice of caveolin-1 (J, red) or flotillin-1 (K, red) HPV-
16 AF488 (green) fluorescence of HeLa cells infected for 8 h. Boxed regions were enlarged as insets. (J) HeLa cells were infected with HPV-16 AF488
for 2 or 8 h, fixed with paraformaldehyde and immunostained for caveolin-1 or flotillin-1. Samples were analyzed by confocal laser scanning
microscopy (cLSM) and the colocalization indices were determined as described in material and methods. Asterisk indicates a significant Costes P-
value.
doi:10.1371/journal.ppat.1002657.g002
Figure 3. HPV-16 entry is dynamin-2-independent. HeLa cells were transfected with constructs expressing wildtype (WT, black) or the DN K44A
(grey) dynamin-2-GFP. 24 h post transfection cells were infected with HPV-16 PsV dsRed (A), SFV (B), or SV40 (C), infection was scored by flow
cytometry as described in Figure S2B in relation to the level of overexpressed dynamin-2 (low, medium high). Depicted are results normalized to GFP
expressing control cells. (D) HeLa cells were pretreated for 30 min with dynasore in the indicated concentrations. Cells were infected with HPV-16 PsV
(black), SFV (grey), or SV40 (white) and analyzed as in Figure 2C.
doi:10.1371/journal.ppat.1002657.g003
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when the phosphatase classes PP1, PP2A, and PP2B were
inhibited by okadaic acid, or PP1 by tautomycetin, SFV infection
was largely unaffected whereas HPV-16 and SV40 infection was
blocked (Figure 5C, Table S1).
To further analyze signaling in the context of HPV-16
endocytosis, we inhibited major kinases involved in macropinocy-
tosis such as EGF receptor tyrosine kinase (EGFR), protein kinase C
(PKC), PI3 kinase (PI3K), and p21-activated kinase (PAK-1) [44].
Inhibition of EGFR signaling by Iressa blocked HPV-16 and VV
but not SFV entry (Figure 5D). Also, PKC signaling was required
for HPV-16 infection as indicated by the inhibitory effects of
calphostin C and rottlerin (Figure 5E, Table S1). Inhibition of PI3K
by wortmannin or PI-103 reduced HPV-16 infection by 50–60%,
which indicated some involvement (Figure 5F, G). Inhibition of
PAK-1 by IPA-3 blocked HPV-16 and VV but not SV40 infection
(Figure 5H). Also, HPV-16 and VV but not VSV entry were
reduced in PAK-1 depleted cells (Figure 5I).
Figure 4. HPV-16 entry requires actin dynamics but not Rho-GTPase or Arf6 signaling. HeLa cells were pretreated for 30 min (A, B, G) or
overnight (C) with cytochalasin D (A), jasplakinolide (B), C3 toxin/toxin B (C), and EIPA (G) in the indicated concentrations. Cells were infected with
HPV-16 PsV (black), SFV (grey), or SV40 (white) and analyzed as in Figure 2C. Alternatively, HeLa cells were transfected with Cdc42, Rac1, RhoA (D, E),
or Arf6 (F) fused to mRFP. Either the wildtype (WT, black), the DN (grey), or the CA (white) mutant were used. 24 h post transfection cells were
infected with HPV-16 PsV (D) or VV (E). Infection was scored by flow cytometry as in Figure 3A–C. Depicted are results normalized to mRFP expressing
control cells.
doi:10.1371/journal.ppat.1002657.g004
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signaling. The signaling factors included EGFR, phosphatases,
PKC and PAK-1, possibly additional tyrosine and serine/
threonine kinases, and potentially PI3K. This list of signaling
components is similar to the signaling activating macropinocytosis.
To test whether the required cell factors were also critical in
more physiologically relevant cells, we infected pharmacologically
perturbed HaCaT cells, i.e. spontaneously immortalized keratino-
cytes. There was virtually no difference between HeLa and
HaCaT cells suggesting that HPV-16 entry occurred by a similar
endocytic mechanism (Figure S4).
Cell binding and endocytosis of HPV-16
To test whether any of the inhibitors affected HPV-16 binding
to cells we measured the association of fluorescent viruses with
perturbed HeLa cells. As a positive control, we blocked cell
binding by preincubation of PsV with soluble heparin, as
previously described [11,13,52]. Alternatively, chlorate treatment
of cells was used, which results in undersulfation of GAG chains
that the virus uses as attachment factors. In both cases, a dramatic
reduction in binding was observed (Figure 6A). When we used a
variety of inhibitors that did or did not perturb HPV-16 entry, no
significant reduction in binding was observed (Figure 6B). Only
Figure 5. Signaling events required during HPV-16 entry. (A–H) HeLa cells were pretreated for 30 min with genistein (A), H-7 (B), okadaic acid
or orthovanadate (C), iressa (D), calphostin C (E), wortmannin (F), PI-103 (G), or IPA-3 (H) in the indicated concentrations. (A–C, E–G) Cells were
infected with HPV-16 PsV (black), SFV (grey), or SV40 (white) and analyzed as in Figure 2C. (D) Cells were infected with HPV-16 PsV (black), SFV (grey),
or VV (white). Infection was scored by automated microscopy and image analysis as in Figure 2C (HPV-16, VV) or by flow cytometry (SFV). (H) Cells
were infected with HPV-16 PsV (black), SV40 (grey) or VV (white). Infection was scored by automated microscopy and image analysis as in Figure 2C
(HPV-16, VV) or by flow cytometry (SV40). (I) HeLa cells were transfected with siRNA oligos directed against PAK-1 or with the AllStar Negative control
(Qiagen). 48 h after siRNA transfection cells were infected with HPV-16 PsV (black), VSV (grey), and VV (white). Infection was scored as in Figure 2C
and depicted relative to cells transfected with the AllStar negative control.
doi:10.1371/journal.ppat.1002657.g005
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cyclodextrin showed a minor reduction in binding that correlated
with a small reduction in infection, which suggested a general
membrane-receptor perturbing effect of the drug as nystatin/
progesterone had no effect.
To analyze which factors contributed to endocytic internalization
as opposed to intracellular events prior to acid-activation we
employed the internalization assay for infective particles and
compared it to the infection assay with inhibitor swap (compare
Figure 1A, Figure S1, S2, material and methods). The relative
amount of internalized infectious particles was analyzed at 12 h,
when the drug was washed out, and a high pH wash inactivated
extracellular virus, so that infection could only be caused by already
internalized virus. Infection was continued the absence of an
inhibitor for further 36 h. To control for the general reversibility of
drug treatment and for cytotoxicity, we included samples where we
did not subject cells to a high pH wash. Any samples where
reversibility of the inhibitors of interest was significantly affected
were excluded. As a positive control, we used chlorate treatment.
Infectious internalization and infection were found to be
similarly reduced by cytochalasin D (actin polymerization),
jasplakinolide (actin depolymerization), EIPA (Na
+/H
+ exchang-
er), genistein (tyrosine kinases), PI-103 (PI3K), IPA-3 (PAK-1), and
H-7 (serine/threonine kinases) (Figure 6C). Although infection was
reduced, internalization was only slightly perturbed by treatment
of cells with orthovanadate (phosphatases), or unaffected by
bafilomycin (endosomal pH), and nocodazole (microtubules)
suggesting a role in intracellular routing of the virus. Nystatin/
progesteron (cholesterol), blebbistatin (myosin II), and ML-7
(myosin light chain kinase) did not affect HPV-16 internalization
or infection, as expected. We concluded that endocytic internal-
ization of HPV-16 required actin polymerization dynamics, the
function of the Na
+/H
+ exchanger, tyrosine and serine/threonine
kinases, PAK-1, and PI3K signaling. Intracellular steps required
phosphatases, microtubules, and acid-activation.
Then, we assessed internalization of HPV-16 particles (as opposed
to infectious units) using a trypan blue based assay [35]. Addition of
the membrane impermeable trypan blue to cells quenched the
fluorescence of AF594 labeled particles bound to cells, whereas the
fluorescence of internalized particles was unaffected (Figure S5).
Microscopicanalysisshowedthate.g.cytochalasinDrenderedalmost
allHPV-16particlessusceptibletotrypanblue consistent with ablock
in internalization, whereas e.g. NH4Cl and nocodazole did not
(Figure 6D). Since this data correlated with our infectious
internalization analysis (Figure 6C, D; data not shown), we concluded
that HPV-16 particles were not internalized and not channeled into a
non-infectious uptake pathway but stalled at the cell surface.
Morphology of HPV-16 internalization
Using thin section electron microscopy, we analyzed the
morphology of HPV-16 internalization in HeLa and HaCaT cells.
Bound viruses were readily detectable at the plasma membrane
(Figure 7A). Occasionally, viruses appeared to cause a slight
indentation in the plasmamembrane (Figure 7B). From 1–24 h post
warming, viruses were mainly observed in indentations 65–120 nm
in diameter without a visible coat (Figure 7D, H, I) but not in
clathrin coated pits (Figure 7F, data not shown). Occasionally, these
indentations were wider or tubular and held several particles
(Figure 7E, not shown). The particles had a distance of about 5–
10 nm from the membrane. About 10–20% were associated with
membrane protrusions resembling filopodia, which we have
previously shown to be capable of binding and transporting HPV-
16 (Figure 7H, [7]). Virus containing indentations were occasionally
located at the base of such protrusions (Figure 7H). In close
proximity to the plasma membrane, viruses were observed in small
vesicles (70–140 nm in diameter) that held one or sometimes two
particles (Figure 7C, D, J). Our data suggested that viruses were
internalized via such small uncoated pits and vesicles that could
accommodate one or possibly several particles.
When virus internalization was blocked using cytochalasin D to
inhibit actin polymerization, virus particles were found in deep,
narrow, almost tubular invaginations of the plasma membrane
that varied in length from a few 100 nm to microns where viruses
occurred in tight rows (Figure 7G, K). Thus, the endocytic pits
containing viruses seemed to grow into long tubules unable to
separate from the plasma membrane by scission. In addition to
implicating actin polymerization in scission, this suggested that
viruses were internalized after sinking into plasma membrane
rather than by protrusive engulfment, which would often be seen
during macropinocytosis.
Intracellular trafficking of HPV-16
After endocytic internalization, most incoming animal viruses
are delivered to endosomes and their penetration into the cytosol
occurs either in early or late endosomes (EE, LE). If the viruses are
endocytosed by macropinocytosis or related mechanisms, the
agenda is less well characterized. Macropinosomes can recycle to
the plasma membrane or fuse with endosomes or lysosomes at
different levels of the pathway [44]. They acidify and it is possible
that they undergo a maturation of their own before fusing with
lysosomes.
Previous studies have shown that entry of a variety of
papillomaviruses is blocked by agents that raise the pH in
endosomes and lysosomes [5,6,8,22,53]. We confirmed that HPV-
16 infection, both in HeLa and HaCaT cells, is reduced by the
weak base NH4Cl, which neutralizes endosomal pH, and by other
inhibitors of endosomal acidification such as bafilomycin A1 and
monensin (Table S1, not shown). Hence, endocytosis carries
viruses to acidic compartments, where low pH-based activation for
penetration or uncoating likely occurs.
To determine when the virus passed the acid-activated step
during entry, we added NH4Cl and bafilomycin A1 at various
Figure 6. HPV-16 cell binding and internalization. (A, B) HeLa cells were seeded in optical bottom 96-well plates to result in a confluent
monolayer at the day of experimentation. Cells were pretreated with chlorate (A, overnight) or further small compound inhibitors (B, 30 min) in the
indicated concentrations. Subsequently, HPV-16 AF488 (A, B) or HPV-16 AF488 preincubated with the indicated concentrations of heparin (A) was
bound to cells for 1 h, after which cells were fixed with paraformaldehyde. Binding of HPV-16 to cells was analyzed by determining cell associated
fluorescence in a sensitive plate reader. The cell associated fluorescence is depicted relative to solvent treated control cells. (C) HeLa cells were
pretreated with small compound inhibitors (concentrations as in A, B). Subsequently, cells were infected with HPV-16 PsV in the presence of inhibitor.
Cells were treated either treated with high pH buffer at 12 h p.i. to inactivate extracellular virus and infection was continued in the absence of
inhbitor (infectious internalization) or the inhibitor was washed out and replaced by NH4Cl. (infection). Note that orthovanadate, bafilomycin, and
nocodazole inhibit infection but not internalization. The amount of GFP expressing cells relative to solvent treated control cells is given as relative
internalization in %. (D) HeLa cells were pretreated with small compound inhibitors for 30 min (concentrations as in A, B). Subsequently, cells were
infected with HPV-16 AF594 in the presence of inhibitor. At 6 h p.i., trypan blue (0.008%, w/v) was infused to quench the fluorescence of extracellular
virus. Images depict the same cell prior and after trypan blue infusion.
doi:10.1371/journal.ppat.1002657.g006
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longer be perturbed at a certain time, the viruses must have passed
the acid-activation step. Our results indicated that about half of
the virus population had passed the low pH dependent step by 13–
16 h in HeLa and HaCaT cells (Figure 8A). This means that the
critical acid exposure occurred 2–3 h after endocytosis (compare
Figure 1A, B). We confirmed previous findings that infection can
be blocked by nocodazole-induced depolymerization of microtu-
bules suggesting a need for intracellular transport of endocytic
vacuoles or the virus itself (Figure 9A, [6,23]). Since nocodazole
add-on experiments followed a similar time course (not shown), we
assume that microtubule-based intracellular sorting of endosomes
is required for successful HPV-16 infection.
Progression in the endocytic pathway involves the risk that viral
particles are degraded. We infected cells at a low MOI in the
presence of NH4Cl and subsequently washed out NH4Cl at
various times. The virus remained infectious for prolonged times
exhibiting 80% infectivity even after a washout at 24 h p.i.
(Figure 8B). Thus, the viruses were not rapidly routed to
compartments, where they were inactivated after acidification.
To analyze the average time that viruses require for acid-
activation, we infected cells in the presence of NH4Cl. After 12 h,
we washed out NH4Cl which results in a fast re-acidification of
endosomes and lysosomes [54]. At various times after washout, we
re-added NH4Cl, and thus created a time window of virus
exposure to low pH. When infectivity was quantified, we found
that the halftime of activation was 6 h (Figure 8C), a surprisingly
long time period suggesting that to be infectious the virus had to be
exposed to low pH, or an enzyme requiring low pH for several
hours. That the long time period was specific to HPV-16, is shown
by the fact that the low pH based activation of VSV occurred
almost completely within a time window of 15 min. (Figure S6).
Since most transport steps in the endocytic pathway are
regulated by Rab GTPases, we analyzed which of several
RabGTPases were required for HPV-16 infection. We overex-
pressed GFP- or RFP-tagged Rab GTPases either as wildtype, or
in the form of DN or CA mutants.
The DN and CA mutants of Rab5 reduced HPV-16 infection
when highly overexpressed (Figure 9B). To control for the efficiency
of the dominant effect, we used SFV and VSV as controls, which
both require Rab5-mediated transport to EEs for infection. Since
the infectivity of both was similarly reduced (Figure 9B), we
concluded that HPV-16 required Rab5. No requirement for Rab7
was detected (Figure 9C, left panel). As a positive control, we
infected cells with IAV that requires Rab7 for transport to the LE
compartment [55]. Since infection of IAV was reduced by the DN
mutant, we concluded that HPV-16 was Rab7-independent
(Figure 9C, right panel). Overexpression of Rab1, Rab4, Rab6,
Rab11 and their mutants did not affect infection (Figure S7).
When the localization of HPV-16 with EE markers was
analyzed, we found no significant colocalization of virus with the
EEA1 from 30 min -2 h or at 8 h (Figure 9D, E, data not shown).
However, we readily found AF488 labeled particles that co-
migrated with Rab5 positive structures in live cells (Video S2). The
time period spent in the Rab5-positive compartments may be
fairly limited as exemplified in Video S2 by a virus entering a
Rab5-positive, virus containing vacuole that loses the Rab5 signal
about 90 s after this event.
Colocalization of HPV-16 with the LE and lysosome marker
LAMP-1 was detectable at 8 h p.i. (Figure 9D, F). Since the
localization of LAMP-1 in the crowded perinuclear space may
introduce artifactual values for colocalization, we analyzed
colocalization with giantin, a Golgi marker. No significant
colocalization was observed (Figure 9D, G). We concluded that
PsV were trafficked to perinuclear, LAMP-1 containing, acidic
compartments. Virus was transported to these vacuoles in the
presence of NH4Cl (Figure 9D, G). Combined with the fact that
after NH4Cl washout the virus remained infectious (compare
Figure 8B), this result suggested that the transport occurred to LEs
or endolysosomes, and that this represented the infectious route.
EM showed the virus frequently in multivesicular bodies
(Figure 10B, C) and lysosomes (Figure 10D), and occasionally in
large endosomal vacuoles that lacked internal vesicles (Figure 10A).
They were not observed in the Golgi complex, the endoplasmic
reticulum (ER), or the cytosol. Interestingly, virus particles were
detectable even late during infection in lysosomal compartments,
which suggested that despite the fact that BrdU labeled DNA of
PsV become accessible to antibody staining [56], they were not
degraded and remained as recognizable particles.
In summary, our data were consistent with intracellular
transport of HPV-16 to the LE/lysosomes. During transport the
virus-containing vacuoles underwent a transient Rab5 association.
Discussion
The cell biological experiments presented here indicated that
entry of HPV-16 into tissue culture cells involves strategies
different from those described for most other viruses. Instead it
involves signaling-dependent formation of small invaginations and
vesicles at the plasma membrane devoid of detectable coats. The
cellular factors needed to generate the PEVs are similar but not
identical to those involved in macropinocytosis. After endocytosis,
the viruses are deposited into acidic organelles with similarities to
classical endosomal compartments and macropinosomes. Clearly,
the uptake process in HeLa and HaCaT cells does not depend on
CME as previously proposed [5,6,8,22].
Internalization and intracellular trafficking of HPV-16 occurs
exceptionally slowly and asynchronously. In agreement with
previous reports [6,23,24], infectious internalization of a pre-
bound cohort of viruses lasted over a period of no fewer than 20 h
with a t1/2 of 11 h. Judging by the timing of the critical acid-
exposure step, a microtubule-dependent step, and the arrival in
LAMP-1-containing vacuoles, the average time that viruses spent
in endocytic organelles before penetration into the cytosol was 2-
3 h. For efficient infection, the viruses had to be exposed to acidic
pH in the endosomal pathway for several hours. In comparison,
viruses such as VSV and SFV are internalized within minutes and
acid-activated penetration takes place a few minutes thereafter
(compare Figure S6) [37,57]. Failing to penetrate, they follow the
classical endosome pathway and begin to be degraded in
lysosomes within 30 min. The only other viruses with compara-
tively slow entry kinetics are the polyomaviruses. For example
SV40 takes 6–12 h to reach the ER where penetration occurs
[58,59].
Initial binding of HPV-16 particles to the cell surface occurs
rapidly and with high affinity [60]. In a mouse vaginal model,
Figure 7. Ultrastructural morphology of HPV-16 internalization. HeLa (A–G) or HaCaT (H–K) cells were infected with HPV-16 PsV (10–20,000
particles/cell) for different times prior to fixation by glutaraldehyde. Cells were either untreated (A–F; H–J) or treated with cytochalasin D (10 mg/ml)
throughout infection (G, K). Cells were processed for thin section electron microscopy according to standard procedures. Depicted are representative
micrographs for 2–4 h p.i. (A–F; H–J) or 6 h p.i. (G, K). Scale bars represent 100 nm.
doi:10.1371/journal.ppat.1002657.g007
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HSPGs [14,20], whereas in human tissue culture cells ECM
binding can in addition involve laminin-332 (previously named
laminin-5, [15]). Proteoglycan-bound viruses undergo a structural
change that subsequently allows further changes conferred by
cyclophilins and furin [16,17]. A conserved epitope in the minor
capsid protein L2 is exposed [18]. This is crucial for infection, and
probably followed by transfer of the virus to an unidentified
secondary cell surface receptor [18,21].
Live cell microscopy showed that the internalization event as
such is rapid. It occurs on average within 2 minutes once lateral
movement of the virus has stopped. It is possible that viruses can
Figure 8. Kinetics of HPV-16 acid-activation during entry. (A) HeLa or HaCaT cells were infected with HPV-16 with different multiplicities of
infection (MOI, in transducing units/cell). At different times p.i. NH4Cl (straight lines) or Bafilomycin A1 (striated line) was added, and infection was
continued in the presence of the drug. (B) HeLa were infected with HPV-16 at MOI 0.1 (10 particles/cell) in the presence of NH4Cl (straight line). At
different times p.i., the drug was washed out as indicated, and infection was continued in the absence of the drugs. (C) HeLa were infected with HPV-
16 as in (B) in the presence of NH4Cl. 8 h p.i., the drug was washed out, and infection was continued in the absence of the drug for indicated times,
after which NH4Cl was re-added and infection was continued in the presence of the drug, thus creating a time window of drug absence. (A–C)
Infection was scored 48 h p.i by flow cytometry. Depicted are results normalized to untreated control cells.
doi:10.1371/journal.ppat.1002657.g008
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and have been transferred to the new receptor. This means that
the changes induced by cyclophilin and furin, or the transfer to the
secondary receptor may be rate-limiting for internalization. This
step-wise process would thus occur asynchronously followed by a
fast endocytic internalization. Viruses would then be endocytosed
one at a time causing a protracted internalization time course seen
in the virus population. Since the structural changes occur when
the viruses are bound to the ECM as shown in mouse vaginal
tissue [20], transfer from the ECM to the cell body may also take a
long time. The transfer from ECM to cells is probably promoted
by actin- and myosin II-mediated transport of viruses along
Figure 9. Intracellular vesicular transport of HPV-16 leads virus particles to the late endosomal/lysosomal compartments. (A) HeLa
cells were pretreated for 30 min with nocodazole in the indicated concentrations. Cells were infected with HPV-16 PsV (black), SFV (grey), or SV40
(white) and analyzed as in Figure 2C. (B, C) HeLa cells were transfected with Rab5 (B) or Rab7 (C) fused to a mRFP tag. Either the wildtype (WT, black),
the DN (grey), or the CA (white) mutant were used. 24 h post transfection, cells were infected with HPV-16 PsV, SFV, VSV, or IAV as indicated. Infection
was scored by flow cytometry as in Figure 3A–C. Depicted are results normalized to mRFP expressing control cells. (D) HeLa cells were infected with
HPV-16 AF488 for 2 or 8 h, in the presence (white) or absence (black) of 20 mM NH4Cl, fixed with paraformaldehyde and immunostained for EEA1,
LAMP-1, or giantin. Samples were analyzed by confocal laser scanning microscopy (cLSM) and the relative amount of the colocalization index was
determined as described in material and methods. Asterisk indicates a significant Costes P-value. (E–G) Merge images of a single cLSM slice of EEA1
(E), LAMP-1 (F), or giantin (G) (red) and HPV-16 AF488 (green) fluorescence of HeLa cells infected for 8 h.
doi:10.1371/journal.ppat.1002657.g009
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cells [7].
Since internalization was strongly dependent on cell signaling, it
was most likely a virus-induced process. Inhibitor analysis showed
that the signaling cascade included the EGFR as well as other
tyrosine and serine/threonine kinases such as PAK-1 and PKC. In
addition, PI3K signaling was required, which was previously
identified to be required for entry of HPV 6b, 18, 31, and 35 or
foruptakeofHPV-16intolangerhanscells[61,62].Theinvolvement
of the EGFR and the other downstream signaling kinases was
reminiscentofmacropinocytosis,whichisoftenactivatedbyreceptor
tyrosine kinases and requires a series of further kinases. Another
kinase that may additionally be involved in HPV-16 endocytosis is
the FAK [63]. That the signaling cascade was modulated, was
suggested by the requirement for cellular phosphatases.
Endocytosis and infection were clearly independent of CME.
Clathrin, AP-2, and dynamin were not needed, and HPV-16
particles did not co-internalize with clathrin-light chain-RFP, or
co-localize with endogenous clathrin heavy chain (not shown).
Internalization took place in smooth, uncoated pits. That
chlorpromazine blocked infection and internalization of HPV-16
particles may be explained by pleiotrophic effects of the drug.
Namely, chlorpromazine can interfere with the formation of
phagosomes or macropinosomes [64,65], cause inhibition of PLC-
regulated actin rearrangements [66,67], and change plasma
membrane fluidity [68]. Also, HPV-16 entry did not occur by a
dynamin-, caveolin-, flotillin-, lipid raft-, or Arf6-mediated
mechanism, thus excluding a role for other often reported
micropinocytic pathways (compare [41,51]). Two previous studies
implicated caveolin-1 and dynamin-2 in HPV-16 infection in
Figure 10. Ultrastructural morphology of HPV-16 intracellular trafficking. HeLa cells were infected with HPV-16 PsV (10–20,000 particles/
cell) for 12 h (A, B) or 18 h (C, D) prior to fixation by glutaraldehyde. Cells were processed for thin section electron microscopy according to standard
procedures. Scale bars represent 250 nm.
doi:10.1371/journal.ppat.1002657.g010
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pertubation were marginal, cell toxicity due to caveolin-1
depletion high, and no positive and negative controls were
employed [4,69].
Actin polymerization and depolymerization was critical for
HPV-16 endocytosis. That long, virus-filled, tubular invaginations
were formed in the plasma membrane of cytochalasin D-treated
cells suggested that actin was required for scission of endocytic
vesicles and not for the generation of membrane protrusions as
observed for macropinocytosis. The lack of protrusions was
supported by electron microscopy data, and the lack of ruffling
or bleb formation by light microscopy ([7], not shown). Moreover,
the dynamics of actin were not regulated by the classical Rho
GTPases, Cdc42, Rac1, and RhoA. In contrast to macropinocy-
tosis which occurs via large, irregularly shaped, fluid-filled
vacuoles, the HPV-16 was observed in small invaginations in the
plasma membrane (65–120 nm in diameter). These lacked any
visible coat structure. Scission resulted in the formation of small
endocytic vacuoles that held one or occasionally two virus
particles.
Obviously, many details in the process of vesicle formation
remain unclear. We do not know how membrane curvature
beneath the virus is induced, how growing pits are stabilized, how
and when constriction and membrane scission occur, and how
these events are coordinated in time and space. Numerous cellular
proteins are likely to be involved in this process. Tetraspanin-
enriched microdomains have been suggested as entry platforms for
HPV-16 endocytosis [9], and may serve as scaffolds for the
recruitment of cytosolic proteins and as a signaling platform.
After endocytosis, the viruses were briefly associated with Rab5-
containing vacuoles, and Rab5 was also required for infection.
Whether the Rab5-containing structures were EEs is not clear,
because no significant colocalization with another marker of EEs,
EEA1, could be observed. The viruses were further transported to
LE and lysosomes positive for Rab7 and LAMP1. It is possible that
the virus bypassed EEs, and like macropinosomes and phagosomes
entered the endocytic pathway at the level of LEs or endolyso-
somes [70].
Two to three hours after internalization the virus passes through
a low pH-dependent step critical for infection. It is unclear at this
point, whether it involves structural changes triggered in the virus
triggered directly by low pH, a block in endosome trafficking and
fusion [71], or the impaired function of endosomal proteases [72].
The combination of low pH-dependent activation and action of
endosomal proteases after proper trafficking may result in a major
uncoating step. There is evidence the viral genome and the minor
capsid protein L2 are exposed in a process most likely triggered by
the shedding of at least a part of L1 [56]. Remarkably, even after
18 h within LE/lysosomal compartments virus particles appeared
to be intact by EM. Potentially, the virus could fully uncoat only
after or during translocation into the cytosol. Penetration through
the vacuolar membrane has been suggested to involve exposure of
a membrane destabilizing peptide in L2 [73]. Before they can
enter the nucleus, the viruses use microtubule-dependent transport
mediated by an interaction between L2 and dynein [74].
Taken together, the cell biological features of HPV-16
endocytosis and intracellular trafficking showed several similarities
with macropinocytosis. In Table 1, we have listed some of the
known properties of macropinocytosis as well as their manifesta-
tion during vaccinia virus entry. When compared with the results
on HPV-16 endocytosis, the strong dependence of HPV-16 on
actin dynamics, receptor tyrosine kinases, PKC, PAK-1, and the
Na
+/H
+ exchanger are consistent with a macropinocytic mech-
anism [44]. In particular, the requirement for receptor tyrosine
kinases, PAK-1 and the Na
+/H
+ exchanger suggest that the
signaling pathway is shared [44]. However, HPV-16 endocytosis
did not involve formation of ruffles or other types of plasma
membrane protrusions. The role of actin was rather connected to
the pinching off of endocytic vesicles. Cholesterol-rich domains,
myosin II and Rho GTPases were not involved, and the HPV-16
containing endocytic pits and vesicles were small and relatively
homogeneous in shape and diameter. Another difference was that
endocytosis of HPV-16 occurred over prolonged periods of time
and seemed to activate the process locally, whereas e.g. a single
vaccinia virus has been shown to activate macropinocytosis
transiently for about 30 min and on large areas of the plasma
membrane. We have to conclude that HPV-16 endocytosis did not
occur by normal macropinocytosis. The data also did not conform
with what is known about phagocytosis (Table 1).
HPV-16 is most likely not the only virus using this particular
endocytic mechanism for entry. Although IAV can use CME for
uptake, electron and light microscopy have indicated the presence
of a parallel, macropinocytosis-like alternate pathway involving
small pits and vesicles devoid of a clathrin coat [75,76]. Recent
analysis of this pathway revealed dependence on a set of cellular
factors similar to those used by HPV-16 (Table 1, [77]). Note, that
like HPV-16 this pathway does not depend on Rho GTPases.
Other viruses that may follow similar pathways include echo virus
1, a picorna virus, and lymphocytic choriomeningitis virus, an
arena virus [78,79]. A more detailed cell biological analysis of
these viruses will be needed to define whether the mechanims are
the same, whether they too represent variants of macropinocytosis
different enough to be considered a distinct endocytosis pathway
altogether.
In respect to papilloma viruses, it will be important to determine
if the pathway described here applies to HPV-16 infection in
epithelial tissue cells in situ. The common findings on the role of
actin [23,43] and on the requirement of PI3K [61,62] in different
cell types and with HPV subtypes, together with divergent results
on the use of lipid rafts and caveolin for e.g. HPV-31, warrant a
comparative study of different HPV subtypes and papillomaviruses
from warts and raft cultures to adress whether the majority of
HPV subtypes makes use of the same pathway in a variety of cell
types.
Materials and Methods
Cells, antibodies, small compound inhibitors, siRNAs,
plasmids
HeLa and HaCaT cells, and mouse embryonic fibroblasts
(caveolin-1 wildtype and knockout, [35]) were cultured in DMEM
(Invitrogen) containing 10% fetal calf serum. For a full list of
antibodies, inhibitors, plasmids, siRNAs, or reagents used, please
refer to Table S2.
Viruses
HPV-16 PsV containing the pRwB or pCIneo-EGFP plasmid
were produced with the p16sheLL plasmid by the propagation
method described by Buck and colleagues [80]. The PsV were
matured for 24 h in the presence of RNAse to maximize the
purification of PsV containing the reporter plasmid, resulting in an
improved particle to infectivity ratio [80]. All plasmids and
production methods are fully described on the Schiller laboratory’s
website (http://ccr.cancer.gov/staff/staff.asp?profileid=5637).
IAV (H1N1, A/PR 34/8), SFV, SV40, recombinant VSV
(Indiana) expressing GFP (VSV-GFP), recombinant VV (IHD-J)
expressing GFP were produced as described [32,47,57,59,81].
Clathrin- and Lipid Raft-Independent HPV-16 Entry
PLoS Pathogens | www.plospathogens.org 16 April 2012 | Volume 8 | Issue 4 | e1002657Fluorescent labeling of HPV-16 PsV
HPV-16 PsV were covalently labeled with fluorophores as
described [7]. Briefly, purified HPV-16 PsV were incubated for
1 h at room temperature in PBS with a ten-fold molar excess of
Alexa Fluor (AF) succinimidylesters (Molecular Probes) over the
major capsid protein L1. PsV were separated from the labeling
reagent by size exclusion chromatography using NAP5 columns
(GE Healthcare) and stored at 4uC.
Transfection and transient expression
For transfection, cells were trypsinized, pelleted, washed with
PBS and transfected with expression plasmids in Nucleofector
solution R (Amaxa) utilizing program I13 of the Amaxa
Nucleofector according to the manufacturer’s instructions. Cells
were seeded in 12-well plates or on 18 mm coverslips and used for
infection or live cell imaging experiments, respectively, at 6–14 h
post transfection.
TIRF microscopy
Microscopy was performed on a custom modified Olympus IX71
inverted microscope. Modifications included a heated incubation
chamber that surrounded the microscope stage set to 37uC, an
objective-type TIRFM setup from TILL Photonics (Grafeling,
Germany), and a monochromator for epifluorescence excitation
with a controller allowing hardware-controlled fast switching
between total internal reflection fluorescence and epi-fluorescence
excitation and acquisition (TILL Photonics). Images were acquired
using a TILL Image QE chargecoupled device camera and
TILLVISION software (both from TILL Photonics). The total
internal reflection angle was manually adjusted for every experi-
ment. Live HeLa cells on 18-mm coverslips were mounted in
custom-made chambers. 5,000 HPV-16 PsV/cell labeled with AF
dyes were added into the 0.5 ml of medium on the stage. Movies
were recorded at a rate of 2–5 frames per s.
Live cell confocal microscopy
Live cell confocal microscopy was performed on a Zeiss 510
microscope with a confocal laser scanning setup. The confocal
microscope was equipped with a heated incubation chamber set at
37uC. Cells were mounted on 18-mm coverslips in custom-made
chambers, and cells were incubated with normal growth medium.
HPV-16 PsV (500–1,000 particles/cell) were added into the 0.5 ml
of medium on the stage. After 30 min – 4 h post addition of virus
particles to cells image acquisition was performed. Movies were
recorded at a rate of 2 frames per s.
Infection studies and analysis by automated microscopy
For siRNA mediated knockdown experiments, 3,000 cells were
reverse transfected in optical bottom 96-well plates (Nunc) with the
indicated amount of siRNA oligos using Lipofectamine RNAimax
(Invitrogen), and infected 48 h post transfection of siRNAs. In case
of oligos directed against clathrin heavy chain and the AP2 m
Table 1. Comparison of the cellular requirements for macropinocytosis, VV, IAV CME-independent, and HPV-16 endocytosis, and
phagocytosis.
Macropinocytosis
(stimulated by growth factors) VV Influenza A Virus HPV16
Phagocytosis
(Fc receptor)
Phagocytosis
(CR3) Characteristics
ruffling blebbing n.d. small pits* phagocytic cups PM indentation PM morphology
33 3 n.d. 77 Fluid uptake
33 n.d. 7* 3/73 /7 cholesterol
33 3 3 3 3 Actin
33 3 7 * 73 Myosin
33 3 3 3 3 Tyrosine Kinases
33 n.d. 3 n.d. n.d. Ser Thr Kinases
33 3 3 3 3 PI(3)kinase
33 3 3 3 3 Protein kinase C
33 3 3 n.d. n.d. PAK-1
33 7 7 * 37 Cdc42
33 7 7 * 37 Rac1
77 n.d. 7* 73 RhoA
33 3 3 7 7 Na+/H+ exchanger
3/77 7 7 3 3 Dynamin-2
77 n.d. 33 3 Arf1
3/73 n.d. 73 3 Arf6
77 n.d. n.d. 33 AP1
3/73 3 3 3 /73 /7 Acidification
33 3 3 3 3 Rab5
33 3 7 3 3 Rab7
Depicted are characteristics and required factors for macropinocytosis, phagocytosis, and endocytic entry of VV, IAV, and HPV-16. Tick marks indicate that a factor is
required, crosses indicate no requirement, both indicate a cell type/system dependend requirement, and n.d.=not determined. Marked with an asterisk (*) are
differences between macropinocytosis and HPV-16. The data is from this manuscript and (Mercer and Helenius, 2008, Mercer and Helenius 2009, de Vries et al., 2011,
Niedergang and Chavrier, 2005).
doi:10.1371/journal.ppat.1002657.t001
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transfection. For small compound inhibition studies, 5,000 cells
were seeded 24 h prior to experimentation in 96-well optical
bottom well plates. Inhibitors were added at indicated concentra-
tions 30 min or as indicated 12–16 h prior to infection (Figure
S2A). Cells were infected with HPV-16, SV40, SFV, or VV to
result in about 20% infection. For inhibitor studies, the primary
inhibitors were exchanged at 12 or 10 h p.i. against 10 mM
NH4Cl or 5 mM DTT in case of HPV-16 or SV40 infection,
respectively, to reduce cytotoxicity (Figure S2A). After 4%
paraformaldehyde fixation, cells were stained with Hoechst
33258 for cell nuclei and in case of SFV, SV40, and IAV with
antibodies directed against SFV glycoproteins, T-antigen, and
nucleoprotein, respectively, and secondary antibodies conjugated
to Alexa Fluor 488 (Molecular Probes) directed against the
primary antibodies. Nine images per well were acquired for each,
nuclear stain (Hoechst 33258) and infection stain (GFP, or IF
staining for SV40 T-antigen, SFV glycoproteins), on a Pathway
855 automated microscopy station (Becton Dickinson) using a 106
objective (Olympus) employing a laser-based autofocus every
image. Cell numbers and raw infection indices for each well were
determined using a MATLAB-based infection scoring procedure
(The Mathworks) described previously ([35], Figure S2C). The raw
infection indices were normalized to solvent treated control cells or
AllStar negative siRNA transfected control cells to result in relative
infection percentages.
Infection studies by flow cytometry
5610
4 cells seeded in 12-well plates were either transfected as
described above or treated with small compound inhibitors 30 min
prior to infection. Cells were infected with HPV-16 dsRed or GFP,
VSV-GFP, VV-GFP, or IAV to result in 20% infection. Cells were
trypsinized, fixed in 4% paraformaldehyde, and in case of IAV,
immunofluorescence staining for the nucleoprotein was per-
formed. Transfected cells were analyzed by flow cytometry for
the level of transgene expression, grouped into low-, medium-, and
high-expressing cells (Figure S2C), and the subpopulation was
subsequently analyzed for the number of infected cells. The
relative number of infected cells was normalized to cells expressing
only the XFP-tag according to expression levels. Inhibitor treated
cells were normalized to solvent treated control cells.
Immunofluorescence staining and analysis
5610
4 cells were seeded on 18 mm coverslips and infected 16–
24 h post seeding with 500 AF488-labeled HPV-16 particles/cell
for 2 or 8 h. Cells were fixed with 4% paraformaldehyde or in ice-
cold methanol, stained against cellular structures with primary
antibodies (Table S2) and AF594 labeled secondary antibodies
(Molecular Probes). Cells were mounted in Citifluor AF1, and
analyzed on a Zeiss 510 microscope with a confocal laser scanning
setup. Per experiment, at least 10 fields of view were imaged in 5
confocal slices with 3–8 cells/field of view. The degree of
colocalization between virus and cellular structures was assessed
using Bioimage XD (www.bioimagexd.net). The thresholded pixel-
per-pixel colocalization was analyzed in an automated fashion
where significance of colocalization was attributed to a Costes P-
value$0.95 [82].
Binding of HPV-16
30,000 Hela cells were seeded into optical bottom 96-well plates
24 h prior to experimentation to reach confluency. Cells were
pretreated with inhibitors as in the infection studies. AF488 labeled
HPV-16 (5,000 particles/cell) wasadded to eachwell, and incubated
for 1 h at 37uC, when cells were fixed in paraformaldehyde and
stained with Hoechst 33258 for cell nuclei. Cellular and cell
associated fluorescence was analyzed using a Safire
2 plate reader
(Tecan), normalized to solvent controls, and depicted as relative cell
associated fluorescence (relative binding).
Internalization of HPV-16 particles
5610
4 HeLa cells were seeded on glass coverslips 24 h prior to
experimentation. Cells were infected with HPV-16 AF594 (500–
1000 particles/cell) in the presence or absence of inhibitors. 6 h post
addition, coverslips were mounted in custom made chambers, and
the amount of fluorescent viruses/cell was analyzed in live cells on a
Zeiss Observer Z1 microscope equipped with a Yokogawa spinning
disc confocal unit and a heating chamber surrounding the
microscope by acquiring Z stacks. After the initial acquisition,
trypan blue (0.4% (w/v), Invitrogen) was added to live cells in a 1:50
dilution. This immediately shifted the emission spectrum of viruses
on the cell-surface and led to a loss of detectable fluorescence,
whereas the fluorescence of intracellular viruses remained unal-
tered. Images were visually analyzed and representative examples
were depicted as maximum intensity projections.
Infectious internalization of HPV-16
5610
4 HeLa or HaCaT cells were seeded 24 h prior to
experimentation in 12 well plates. HPV-16 PsV were added to
cells in the cold. After 4 h the plates were shifted to 37uC. At
different time points post warming, cells were incubated with high
pH buffer (PBS, pH 10.5) for 1 min, which was replaced by
normal growth medium. The treatment did not cause any cell
toxicity (not shown) but resulted in disassembly of surface bound
virions rendering them non-infectious (Figure S1). Alternatively,
HeLa cells were infected in the presence or absence of inhibitors
with HPV-16 to result in about 20% infection of the unperturbed
control (10–30 particles/cell) At 12 h p.i., cells were incubated for
2 min with the high pH buffer, which was replaced with normal
growth medium without inhbitor causing infection by already
internalized virus. 48 h p.i., cells were trypsinized, fixed in 4%
paraformaldehyde, and analyzed for infection (GFP expression) by
flow cytometry.
Electron microscopy
For thin-section EM, HeLa or HaCaT cells plated onto 12-mm
coverslips were incubated with HPV-16 PsV (10–20,000 particles/
cell) 37uC for 30 min, 2, 6, 12, and 24 h before fixation with 2.5%
glutaraldehyde (in 0.05 M sodium cacodylate pH 7.2, 50 mM
KCl, 1.25 mM MgCl2, and 1.25 mM CaCl2, 30 min at RT),
followed by 1.5 h of incubation in 2% OsO4 on ice. Dehydration,
embedding, and thin sectioning were performed as previously
described [58]. After transmission electron microscopy (Zeiss EM
91 microscope), images were exported as 8-bit TIFF files.
If not otherwise mentioned, all data is depicted 6 standard
deviation from at least three independent experiments.
Supporting Information
Figure S1 HPV-16 infectious internalization assay. (A)
HPV-16 PsV were bound to HeLa cells for 4 h in the cold. Cells
were submitted to a 1 min wash with buffer at indicated pH, after
which cells were washed with medium, and incubated at 37uC for
48 h. Infection was scored by flow cytometry as in Figure 3A–C.
Depicted are results normalized to pH 7.4 treated control cells. (B)
Electron micrographs of negatively stained HPV-16 PsV incubat-
ed in buffers at indicated pHs. Note the complete disassembly of
virions at pH 10.5.
(TIF)
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sis. (A) Schematic representation of the cellular inhibitor studies
for virus infections. Cells were pretreated with tested drugs for
30 min prior to infection (green), if not mentioned otherwise. If
indicated, drugs were re-added 5 h p.i to ensure efficient
inhibition. Infection was carried out for indicated times in the
presence of the drug (orange), when cells were fixed (blue). For
HPV-16 and SV40, tested inhibitor were exchanged for NH4Cl
and DTT blocking acid-activation or escape from the ER,
respectively (red). (B) Scatter plot of HPV-16 infected GFP
transfected HeLa cells. The PsV expressed RFP (y-axis) upon
successfull infection. Transgene expression levels (x-axis) were
grouped into untransfected, low, medium, and high expressing
cells. (C) Infection was analyzed by automated microscopy of
samples. Given are exemplary pictures of nuclear stain (Hoechst),
infection (GFP/AF488), and merges for HPV-16, SV40, and SFV
infections. The data was computationally analzyed, the raw
infection index (infected cells, i.e. green/cell number, i.e. green +
red) was obtained, and data was normalized to solvent treated
control cells on the same plate.
(TIF)
Figure S3 siRNA mediated knockdown of clathrin, AP2,
caveolin-1, flotillin-1 and -2. HeLa cells were transfected with
siRNA oligos directed against the AP2m-subunit (AP2), clathrin
heavy chain (CHC) (A), caveolin-1 (B), flotillin-1, flotillin-2 (C), or
as control against luciferase (A) or an AllStar negative control
(Qiagen, B, C). Protein lysates were subjected to SDS-PAGE and
Western Blotting with antibodies directed against CHC, AP2m,
caveolin-1, flotillin-1, flotillin-2, and actin (loading control) as
indicated. Signals were quantified and normalized to the loading
control and depicted as relative protein abundance (right panel).
(TIF)
Figure S4 Cellular requirements for HPV-16 infection
in HeLa vs. HaCaT cells. HeLa (black) and HaCaT (white)
cells were pretreated with inhibitors at indicated concentrations for
30 min, and subsequently infected with HPV-16 PsV. 12 h p.i.
inhibitors were exchanged for NH4Cl, and infection was
continued for further 36 h. Cells were fixed and analyzed for
GFP expression (infection) by flow cytometry, and infection is
given relative to solvent treated control cells in %. Depicted are the
results for three independent experiments 6 SD.
(TIF)
Figure S5 Trypan blue-based internalization assay of
HPV-16 particles. HeLa cells were infected with AF594 labeled
HPV-16 for 1 h (bound virus) or 12 h (internalized virus). Images
of live cells are depicted before (2) and after (+) addition of trypan
blue that quenches the fluorescence of externally located virus.
(TIF)
Figure S6 Kinetics if VSV acid activation in HeLa cells.
HeLa were infected with VSV the presence of NH4Cl. 30 min p.i.,
the drug was washed out, and infection was continued in the
absence of the drug for indicated times, after which NH4Cl was re-
added and infection was continued in the presence of the drug,
thus creating a time window of drug absence. Infection was scored
6 h p.i by flow cytometry. Depicted are results normalized to
untreated control cells.
(TIF)
Figure S7 HPV-16 entry is Rab1, Rab4, Rab6, and
Rab11-independent. HeLa cells were transfected with Rab1
(A), Rab4 (B), Rab6 (C), or Rab11 (D) fused to a GFP tag. Either
the wildtype (WT, black), the DN (grey), or the CA (white) mutant
were used. 24 h post transfection cells were infected with HPV-16
PsV expressing dsRed. Infection was scored by flow cytometry as
in Figure 3A–C. Depicted are results normalized to GFP
expressing control cells.
(TIF)
Table S1 Additional infection data in the context of cell
perturbations. The upper table summarizes data on virus
infectivity after pharmacological inhibition of cellular targets. HeLa
cells were pretreated for 30 min with pharmacological inhibitors in
the indicated concentrations. Cells were infected with HPV-16 PsV,
SFV, or SV40 in the presence of inhibitor as indicated. Inhibitors
were exchanged for HPV-16 and SV40 with NH4Cl or DTT,
respectively. Infection was scored by automated microscopy and
image analysis. Depicted are results normalized to solvent treated
control cells. See also Figure S2, and material and methods. The
lower table summarizes data on virus infectivity after siRNA
mediated depletion of cellular targets The efficiency of the
knockdown is expressed as the amount of residual mRNA still
present after siRNA transfection. HeLa cells were transfected with
siRNA oligos directed against the indicated targets. Cells were
infected with HPV-16 PsV and infection was scored 36 h p.i. by
automated microscopy and image analysis. Depicted are the mean
infection percentages relative to the the AllStar negative control.
(PDF)
Table S2 List of the antibodies, pharmacological inhib-
itors, plasmids, siRNAs including their suppliers that
were used in this study.
(PDF)
Video S1 HPV-16 internalization occurs independently
of clathrin. HeLa cells were transfected with CLC-mRFP (red).
About 12–16 h post transfection HPV-16 AF488 labeled particles
(green) were added to cells, and imaged 30 min post addition by
TIRFM. Imaging occured at 2 fps, movie played at 10 Hz. Shown
is a cropped area of a single cell. Encircled in white is the area
where an HPV-16 particle becomes confined and is internalized
around halfway through the movie. The encircled area shows the
internalization event that is depicted as kymograph in Figure 1C.
(MOV)
Video S2 HPV-16 association with Rab5. HeLa cells were
transfected with Rab5-mRFP (red). About 12–16 h post transfec-
tiom HPV-16 AF488 labeled particles (green) were added to cells,
and imaged 3.5 h post addition. Imaging occured at 0.5 fps.
Shown is first the whole cell, from where an area oft he cell
periphery is zoomed in. Encircled in white is the area where an
HPV-16 particle started moving towards a Rab5/virus positive
structure, with which it associated, and from where it trafficked
towards the nucleus. During the latter transport the virus lost
association with the Rab5 signal.
(MOV)
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